Genomic Health expects 2015 revenues as high as $286M, $320M - 335M in 2016

• On a preliminary basis, Genomic Health (GHDX -0.5%) expects Q4 and 2015 revenues of $73M - 74M and $285M - 286M, respectively, representing ~4% full-year growth versus 2014, slightly below guidance.
• It delivered more than 106,850 Oncotype DX tests during the year (+12%) and more than 27,520 (+11%) in Q4.
• Final results will be released in early February.
• 2016 Guidance: Revenues: $320M - 335M.